Department of Medical Microbiology, Cardiff University, Chepstow, UK.
Eye (Lond). 2012 Feb;26(2):218-21. doi: 10.1038/eye.2011.314. Epub 2011 Dec 2.
MRSA, first identified in 1960, became a major cause of healthcare-associated infection with the emergence of epidemic strains EMRSA 15 and 16 in the 1990 s. MRSA bacteraemia surveillance in England showed a peak of 7700 in 2003-2004. A target was set to halve MRSA bacteraemias by 2008 backed by a central improvement programme for infection prevention and control. Healthcare-associated infection is a patient safety issue with joint responsibility between: clinicians responsible for patient care; managers responsible for the organisation of services; and the government/Department of Health responsible for national strategy, prioritisation and performance management, together with introducing a statutory Code of Practice. By 2011, the number of MRSA bacteraemias had reduced by 80% to 1481. The key drivers of improvement were management responsibility, enhanced surveillance, adherence to clinical protocols and care bundles for invasive procedures, hand hygiene and environmental cleaning, and improved isolation procedures and antibiotic stewardship. The target has been translated into an ongoing MRSA objective, and further control of MRSA is supported by a screening programme aimed at all relevant hospital admissions. Sustaining the reduction will depend upon joint responsibility between management maintaining compliance assurance with policies and individual clinicians keeping it as a priority in patient safety.
耐甲氧西林金黄色葡萄球菌(MRSA)于 1960 年首次被发现,随着 20 世纪 90 年代流行株 EMRSA-15 和 EMRSA-16 的出现,成为了医疗保健相关感染的主要原因。英格兰的耐甲氧西林金黄色葡萄球菌菌血症监测显示,2003-2004 年达到了 7700 例的峰值。在中央感染预防和控制改善计划的支持下,设定了到 2008 年将耐甲氧西林金黄色葡萄球菌菌血症减少一半的目标。医疗保健相关感染是一个患者安全问题,涉及以下方面的共同责任:负责患者护理的临床医生;负责服务组织的管理人员;以及负责国家战略、优先事项和绩效管理的政府/卫生部,同时引入法定的实践准则。到 2011 年,耐甲氧西林金黄色葡萄球菌菌血症的数量减少了 80%,降至 1481 例。改善的关键驱动因素是管理责任、加强监测、遵守侵入性程序的临床方案和护理包、手卫生和环境清洁,以及改进的隔离程序和抗生素管理。这一目标已经转化为一个正在进行的耐甲氧西林金黄色葡萄球菌目标,通过一项针对所有相关住院患者的筛查计划,进一步控制耐甲氧西林金黄色葡萄球菌。维持这种减少将取决于管理层之间的共同责任,确保政策的合规性,以及个体临床医生将其作为患者安全的优先事项。